What is the appropriate management for a serum potassium of 6.2 mEq/L (moderate hyperkalemia)?

Management of Potassium 6.2 mEq/L

For a potassium of 6.2 mEq/L, immediately obtain an ECG and assess for symptoms; if ECG changes or symptoms are present, give IV calcium gluconate 10% (10 mL) immediately, followed by insulin/glucose (10 units insulin + 50 mL dextrose) and nebulized albuterol (20 mg in 4 mL), then address potassium removal with diuretics or potassium binders. 1

Initial Assessment

First, rule out pseudohyperkalemia before treating—repeat the sample if hemolysis, prolonged tourniquet time, or fist clenching occurred during blood draw. 1 Plasma potassium runs 0.1-0.4 mEq/L lower than serum, so know which your lab reports.

Immediately obtain an ECG regardless of potassium level, as cardiac conduction abnormalities can occur unpredictably and don't always correlate with the degree of hyperkalemia. 1, 2 Look specifically for:

• Peaked T waves
• Prolonged PR interval
• Widened QRS complex
• Loss of P waves
• Sine wave pattern

Assess for neuromuscular symptoms: muscle weakness, paralysis, or paresthesias. 3

Acute Treatment Algorithm

If ECG Changes OR Symptoms Present (URGENT):

1. Membrane Stabilization (1-3 minutes onset):

   • IV calcium gluconate 10%, 10 mL push over 2-3 minutes 1
   • This does NOT lower potassium but protects the heart
   • Can repeat if ECG changes persist

2. Shift Potassium Intracellularly (30-60 minutes onset):

   • IV insulin 10 units + 50 mL of 50% dextrose (or 25g glucose) 1
   • Nebulized albuterol 20 mg in 4 mL 1
   • Use both together for additive effect
   • Monitor glucose closely to prevent hypoglycemia
   • Effect lasts 2-4 hours for beta-agonists, longer for insulin

3. Sodium bicarbonate ONLY if metabolic acidosis is present 1—it's ineffective as monotherapy and should not be used routinely

If NO ECG Changes AND Asymptomatic:

You still need to lower potassium, but the urgency is lower. Proceed directly to removal strategies.

Potassium Removal (Essential in All Cases)

These measures actually eliminate potassium from the body:

• Loop diuretics (furosemide) if patient has adequate kidney function and is not oliguric 1

• Potassium binders:

  • Patiromer or sodium zirconium cyclosilicate (SZC) are preferred 3, 4, 5
  • These newer agents are safe, effective, and can be used in acute settings
  • Avoid sodium polystyrene sulfonate (SPS/Kayexalate) due to serious GI adverse effects including bowel necrosis 6, 4

• Hemodialysis if patient has oliguria, ESRD, or refractory hyperkalemia 1

Critical Long-Term Considerations

DO NOT discontinue or down-titrate RAASi therapy (ACE inhibitors, ARBs, MRAs) unless absolutely necessary. 7, 1 This is a common error that increases mortality and cardiovascular events. The 2025 European guidelines emphasize that RAASi discontinuation due to hyperkalemia is associated with:

• Increased all-cause mortality
• More heart failure hospitalizations
• Progression to end-stage kidney disease 7

Instead, manage hyperkalemia through:

1. Identifying and removing other contributing medications (NSAIDs, potassium supplements, salt substitutes)
2. Using potassium binders to enable RAASi continuation 7, 5
3. Optimizing diuretic therapy if volume overloaded
4. Dietary potassium counseling (though evidence for strict restriction is limited) 1

Monitoring

Recheck potassium within 1 week after any intervention or medication adjustment. 1 More frequent monitoring (within 24-48 hours) is warranted if:

• Initial potassium was ≥6.0 mEq/L
• Patient has advanced CKD (eGFR <30)
• Patient is on RAASi therapy
• Recent dose changes of any relevant medications

Common Pitfalls

• Don't rely on ECG absence to exclude urgency—some patients with severe hyperkalemia have minimal ECG changes 2
• Don't forget glucose with insulin—hypoglycemia is a real risk and can be life-threatening
• Don't use sodium bicarbonate routinely—it only works in acidotic patients 1
• Don't stop RAASi reflexively—this worsens long-term outcomes 7, 1
• Don't prescribe SPS/Kayexalate—serious GI complications outweigh benefits when safer alternatives exist 6, 4

Every 0.1 mEq/L rise in potassium ≥5.0 mEq/L increases all-cause mortality, making aggressive but appropriate management essential. 7